Talimed Tablet (Talniplumat)

Adult dose

Administer 370 mg of talniflumate per dose orally 3 times daily. For severe cases, administer 740 mg per dose. The dose may be adjusted as appropriate according to age and symptoms.

This medication may cause gastrointestinal bleeding in individuals who regularly consume more than three alcoholic beverages daily, so consultation with a doctor or pharmacist is essential. This medication may increase the risk of cardiovascular diseases, and there is a possibility of serious issues such as myocardial infarction or stroke, so caution is needed for patients with a history or factors of cardiovascular disease. This medication can cause serious adverse reactions such as gastrointestinal bleeding, ulcers, and perforations, especially in elderly patients or those with a history of gastrointestinal disorders. Patients with peptic ulcers or hypersensitivity to this medication or who have experienced allergic reactions to aspirin or other non-steroidal anti-inflammatory drugs should not take this medication. Patients with severely impaired liver, kidney, or heart function, and pregnant or breastfeeding women should also avoid this medication. Patients with mildly impaired liver or kidney function, elderly individuals, and patients taking diuretics should use this medication cautiously and monitor their condition according to a doctor's instructions. This medication may cause gastrointestinal symptoms such as nausea, vomiting, diarrhea, and abdominal pain, and rarely cardiovascular issues, skin rashes, dizziness, and renal function abnormalities; thus, any abnormal symptoms should be reported immediately. Long-term use of this medication requires regular blood tests and liver/kidney function tests, and dosage adjustments may be necessary if abnormalities are found. This medication helps alleviate inflammation and pain, but it does not treat the underlying condition, so it should be used alongside treatment of the root disease. Interactions may occur if taken with other anti-inflammatory drugs or certain medications, so any ongoing prescriptions must be disclosed. This medication should not be taken during pregnancy, especially in the late stages, as it may be harmful to the fetus; caution is also needed for breastfeeding, as safety has not been established. Children under 12 years old should not use this medication, and elderly individuals should be given the minimum dosage cautiously with attention to side effects. This medication should be kept out of the reach of children, and it is safer not to transfer it to other containers.

• Gastrointestinal bleeding
• cardiovascular thrombotic events
• myocardial infarction
• stroke
• nausea
• vomiting
• photosensitivity
• asthma attacks
• hypotension
• general fatigue

This medication should be stored in an airtight container and preferably at room temperature between 1°C and 30°C. Proper storage will maintain the drug's effectiveness and prevent degradation.

Appearance

Pale yellow, round film-coated tablet

Package unit

30 tablets/bottle, 500 tablets/bottle